Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.41 |
| ▸ | FEN1 | P39748 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2154238 | 1.00 | ALDH1A1 (0.47) | ALDH1A1POLBCES2CES1L3MBTL1 | |
| SCHEMBL2154017 | 0.81 | HPGD (0.43) | POLBL3MBTL1HPGDKDM4EERCC5 | |
| SCHEMBL8846182 | 0.81 | HPGD (0.43) | POLBL3MBTL1HPGDKDM4EERCC5 | |
| SCHEMBL6626532 | 0.81 | LMNA (0.47) | ALDH1A1HPGDKMT2AKDM4EMAPT | |
| SCHEMBL2154230 | 0.81 | LMNA (0.47) | ALDH1A1HPGDKMT2AKDM4EMAPT | |
| SCHEMBL2154229 | 0.81 | LMNA (0.47) | ALDH1A1HPGDKMT2AKDM4EMAPT | |
| SCHEMBL2154012 | 0.81 | HPGD (0.43) | POLBL3MBTL1HPGDKDM4EERCC5 | |
| SCHEMBL2154734 | 0.77 | HPGD (0.44) | ALDH1A1L3MBTL1HPGDKMT2ARAB9A | |
| SCHEMBL2154731 | 0.77 | HPGD (0.44) | ALDH1A1L3MBTL1HPGDKMT2ARAB9A | |
| SCHEMBL8109438 | 0.77 | HPGD (0.44) | ALDH1A1L3MBTL1HPGDKMT2ARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105399666-A | Fungicide hydroxyimino-heterocyclic derivatives | BAYER CROSPSCIENCE AG | 2016-03-16 | — | — | CN | claimed |
| US-20130040993-A1 | FUNGICIDE HYDROXIMOYL-HETEROCYCLES DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2013-02-14 | — | — | US | claimed |
| EP-2519502-A2 | FUNGICIDAL HYDROXIMOYL-HETEROCYCLES DERIVATIVES | Bayer CropScience AG (DE) | 2012-11-07 | — | — | EP | claimed |
| CN-102725270-A | Fungicide hydroxyimino-heterocyclic derivatives | BAYER CROPSCIENCE AG | 2012-10-10 | — | — | CN | claimed |
| WO-2011080254-A2 | FUNGICIDE HYDROXIMOYL-HETEROCYCLES DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2011-07-07 | — | — | WO | claimed |
| CN-105399666-A | Fungicide hydroxyimino-heterocyclic derivatives | BAYER CROSPSCIENCE AG | 2016-03-16 | — | — | CN | disclosed |
| CN-102725270-B | Fungicide hydroxyimino-heterocyclic derivatives | BAYER CROPSCIENCE AG (DE) | 2015-10-07 | — | — | CN | disclosed |
| US-9000012-B2 | Fungicide hydroximoyl-heterocycles derivatives | BAYER CROPSCIENCE AG (DE) | 2015-04-07 | — | — | US | disclosed |
| US-20130040993-A1 | FUNGICIDE HYDROXIMOYL-HETEROCYCLES DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2013-02-14 | — | — | US | disclosed |
| EP-2519502-A2 | FUNGICIDAL HYDROXIMOYL-HETEROCYCLES DERIVATIVES | Bayer CropScience AG (DE) | 2012-11-07 | — | — | EP | disclosed |
| CN-102725270-A | Fungicide hydroxyimino-heterocyclic derivatives | BAYER CROPSCIENCE AG | 2012-10-10 | — | — | CN | disclosed |
| WO-2011080254-A2 | FUNGICIDE HYDROXIMOYL-HETEROCYCLES DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2011-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130040993-A1 | FUNGICIDE HYDROXIMOYL-HETEROCYCLES DERIVATIVES | HAAO, HPD, CYP51A1 | ALDH1A1 2591/4885POLB 4582/4885CES2 935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.